Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Penciclovir | |
Synonyms |
|
|
Definitions |
A synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes simplex virus (HSV) types 1 and 2. In HSV infected cells, penciclovir is phosphorylated by viral thymidine kinase and subsequently converted by cellular kinases into the active metabolite, penciclovir triphosphate, which competitively inhibits viral HSV polymerase by blocking deoxyguanosine triphosphate substrate binding. As a result, herpes viral DNA synthesis and replication are selectively inhibited. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C66337 |
|
CAS_Registry |
39809-25-1
|
|
CHEBI_ID |
CHEBI:7956
|
|
Chemical_Formula |
C10H15N5O3
|
|
code |
C66337
|
|
Contributing_Source |
FDA
|
|
definition |
A synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes simplex virus (HSV) types 1 and 2. In HSV infected cells, penciclovir is phosphorylated by viral thymidine kinase and subsequently converted by cellular kinases into the active metabolite, penciclovir triphosphate, which competitively inhibits viral HSV polymerase by blocking deoxyguanosine triphosphate substrate binding. As a result, herpes viral DNA synthesis and replication are selectively inhibited.
|
|
FDA_UNII_Code |
359HUE8FJC
|
|
Has_Salt_Form | ||
in_subset | ||
label |
Penciclovir
|
|
Legacy Concept Name |
Penciclovir
|
|
Preferred_Name |
Penciclovir
|
|
prefixIRI |
NCIT:C66337
|
|
prefLabel |
Penciclovir
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0164815
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping